Gan & Lee Pharmaceuticals. (603087.SS)

CNY 45.54

(0.35%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 11.71 Billion 10.6 Billion 10.85 Billion 9.5 Billion 6.02 Billion 4.69 Billion
Total Current Assets 6.17 Billion 5.66 Billion 6.87 Billion 5.95 Billion 3.11 Billion 2.44 Billion
Cash And Short Term Investments 4.85 Billion 4.52 Billion 4.92 Billion 3.61 Billion 1.54 Billion 593.53 Million
Cash and Cash Equivalents 316.48 Million 2.89 Billion 3.3 Billion 2.82 Billion 483.21 Million 593.53 Million
Short Term Investments 4.53 Billion 1.63 Billion 1.62 Billion 787.05 Million 1.05 Billion 584.69 Million
Net Receivables 390.77 Million 241.43 Million 1 Billion 902.58 Million 889.11 Million 871.88 Million
Inventory 860.5 Million 648.64 Million 651.32 Million 493.48 Million 471.34 Million 389.13 Million
Other Current Assets 71.32 Million 247.83 Million 285.95 Million 951.68 Million 208.14 Million 589.54 Million
Total Non-Current Assets 5.53 Billion 4.94 Billion 3.98 Billion 3.54 Billion 2.91 Billion 2.25 Billion
Net PPE 3.91 Billion 3.66 Billion 2.59 Billion 2.14 Billion 1.89 Billion 1.63 Billion
Good Will And Intangible Assets 1.09 Billion 1.02 Billion 872.48 Million 769.62 Million 591.33 Million 422.84 Million
Good Will - - - - - -
Intangible Assets 1.09 Billion 1.02 Billion 872.48 Million 769.62 Million 591.33 Million 422.84 Million
Long-Term Investments 334.65 Million -1.6 Billion -1.39 Billion -321 Million -696.06 Million 1.00
Tax Assets 168.95 Million 138.25 Million 30.8 Million 14.92 Million 1.07 Billion 3.44 Million
Other Non Current Assets 29.43 Million 1.72 Billion 1.87 Billion 935.28 Million 57.37 Million 187.22 Million
Other Assets -0.00 1.00 1.00 1.00 1.00 -
Total Liabilities 792.89 Million 1.02 Billion 686.02 Million 569.09 Million 555.88 Million 424.18 Million
Total Current Liabilities 773.44 Million 813.03 Million 485.53 Million 409.85 Million 458.22 Million 354.3 Million
Account Payables 105.54 Million 44.69 Million 37.74 Million 17.81 Million 30.65 Million 39.32 Million
Tax Payables 1.42 Million 14.41 Million 129.68 Million 66.74 Million 156.65 Million 106.85 Million
Short Term Debt 73.54 Million 7.56 Million 7.95 Million 9.08 Million 38.37 Million 35.86 Million
Deferred Revenue 52.99 Million 68.72 Million 439.72 Million 381.99 Million 298.51 Million 106.85 Million
Other Current Liabilities 541.37 Million 692.05 Million 115.13 Thousand 949.09 Thousand 90.68 Million 172.26 Million
Total Non Current Liabilities 19.44 Million 208.23 Million 200.48 Million 159.24 Million 97.66 Million 69.88 Million
Long-Term Debt 5.44 Million 8.32 Million 12.16 Million 16.12 Million 682.57 Thousand 81.5 Thousand
Deferred Revenue Non Current 179.62 Million 187.63 Million 141.97 Million 125.76 Million 71.06 Million 65.9 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 13.99 Million 12.27 Million 10.19 Million -14.43 Million - 1.00
Other Liabilities 1.00 1.00 - - 1.00 1.00
Total Equity 10.74 Billion 9.58 Billion 10.16 Billion 8.93 Billion 5.47 Billion 4.27 Billion
Stock Holders Equity 10.74 Billion 9.58 Billion 10.16 Billion 8.93 Billion 5.47 Billion 4.27 Billion
Common Stock 594.16 Million 565.65 Million 561.54 Million 561.54 Million 360.9 Million 360.9 Million
Retained Earnings 6.56 Billion 6.23 Billion 6.84 Billion 5.61 Billion 4.74 Billion 3.54 Billion
Accumulated other comprehensive income 338.73 Million 276.28 Million 321.16 Million 320.52 Million 615.78 Million 323.56 Million
Common Stock Equity 10.74 Billion 9.58 Billion 10.16 Billion 8.93 Billion 5.47 Billion 4.27 Billion
Capital Lease Obligation 5.44 Million 8.32 Million 12.16 Million 16.12 Million - -
Total Investments 4.87 Billion 30 Million 231.35 Million 466.04 Million 362.2 Million 1.00
Total Debt 78.98 Million 15.89 Million 20.12 Million 9.08 Million 38.37 Million 35.86 Million
Net Debt -237.5 Million -2.87 Billion -3.28 Billion -2.81 Billion -444.84 Million -557.66 Million

Balance Sheet Charts